[Self-stimulation reaction of the hypothalamus in single and repeat administrations of ethaminal sodium].
Pentobarbital facilitated hypothalamic self-stimulation in doses from 1 to 10 mg/kg intraperitoneally. Under concurrent self-stimulation and intravenous self-administration two phases of pentobarbital action were distinctly revealed--activating and inhibitory. The facilitating effect of pentobarbital was blocked by the antiadrenergic drugs, butyroxane, pyrroxane and carbidine as well as was partially antagonized by naloxone. After chronic treatment (20 mg/kg daily) initial inhibition of self-stimulation was replaced by facilitation by days 3-4 of the experiment. Injection of pentobarbital in a daily dose of 3 mg/kg resulted in gradual development of tolerance to the facilitation action of the drug on self-stimulation and in that of dependence. Two types of abstinence reactions after pentobarbital withdrawal are described. The method proposed appears to be sensitive for studying barbiturate dependence.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D004558:Electric Stimulation; D005059:Euphoria / Q000187:drug effects; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects*; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology*; D051381:Rats; D012054:Reinforcement, Psychology; D012653:Self Stimulation / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000503:physiopathology; D013565:Sympatholytics / Q000494:pharmacology
D013565:Sympatholytics; D010424:Pentobarbital
Reaktsiia samostimuliatsii gipotalamusa pri odnokratnom i povtornom vvedenii étaminal-natriia.